PAA 4.17% 17.3¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-135

  1. 659 Posts.
    lightbulb Created with Sketch. 506
    My pick is J & J, Roche, Merck or Eli Lilly, they are all interested in Neurology and Oncology, and have a lot of cash to spend (no other reason).

    But having said that I don’t have shares in them so I couldn’t care who is the winning bidder in the Auction to come. Pfizer can have it, if they are the highest bidder.

    As long as there is a few interested, and they battle it out.

    @Peeteepoo posted this table:

    https://hotcopper.com.au/posts/71907197/single

    https://hotcopper.com.au/data/attachments/5971/5971639-22580dc8d3328291cc9462f068f48d81.jpg
    Havenots
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.3¢
Change
-0.008(4.17%)
Mkt cap ! $83.90M
Open High Low Value Volume
18.0¢ 18.0¢ 17.3¢ $59.77K 338.7K

Buyers (Bids)

No. Vol. Price($)
13 376984 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 25091 2
View Market Depth
Last trade - 15.42pm 13/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.